Results 241 to 250 of about 401,347 (255)

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease

Lancet, The, 1998
Tamar F Barlam
exaly  

Serine Protease Mechanism and Specificity

Chemical Reviews, 2002
Lizbeth Hedstrom
exaly  

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study

Lancet, The, 2001
Esteban Martinez, Amanda Mocroft, Andrew Phillips   +2 more
exaly  

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Lancet, The, 2010
Paul Y Kwo, John M Vierling
exaly  

Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents

Lancet, The, 2003
James M Oleske, Stephen A Spector
exaly  

Severe premature coronary artery disease with protease inhibitors

Lancet, The, 1998
exaly  

Protease inhibitor-associated hyperglycaemia

Lancet, The, 1997
exaly  

Benign symmetric lipomatosis associated with protease inhibitors

Lancet, The, 1997
exaly  

Protein homeostasis in mitochondria: AAA+ chaperones & proteases

The Biomedical & Life Sciences Collection, 2012
openaire   +1 more source

Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities

Lancet, The, 1998
exaly